Infections with the Highest Risk of Bacteremia
Staphylococcus aureus infections, particularly pneumonia, catheter-related infections, and endocarditis, carry the highest risk of bacteremia with significant associated mortality and complications. 1, 2
Highest Risk Infections for Bacteremia
1. Staphylococcus aureus Infections
- S. aureus pneumonia: Associated with bacteremia in approximately 20% of cases, with a 6-fold increase in mortality risk when bacteremia develops 3
- Catheter-related S. aureus infections: Particularly in intravenous catheters, with mortality increasing over time 1
- Endocarditis: S. aureus is now the most common cause of infective endocarditis in industrialized nations 2
2. Streptococcal Infections
- Pneumococcal infections: S. pneumoniae remains the most common bacterial pathogen in severe community-acquired pneumonia (SCAP) and is responsible for 41.7% of cases and over 80% of all causes of bacteremia in SCAP 1
- Viridans streptococci: High risk for bacteremia and subsequent endocarditis 4
3. Enterococcal Infections
- Enterococcus faecalis/faecium infections: Responsible for 7.2% of bloodstream infections (BSI) in European data 1
- Urinary tract infections with Enterococcus: Particularly high risk in immunocompromised patients 1
4. Gram-negative Infections
- Pseudomonas aeruginosa: Increasing incidence of bacteremia, particularly in immunocompromised patients 1
- Escherichia coli: Leading cause of bacteremia (60%), urinary tract infection (87.4%), and bacterial meningitis (43.7%) in certain populations 1
Risk Factors That Increase Bacteremia Risk
Patient-specific factors:
- Advanced age
- Immunocompromised status (diabetes, medications, AIDS)
- Malignancy
- Prosthetic intravascular devices
- Cardiac valvular disease
- Low serum albumin level 1
Infection-specific factors:
- Pneumonia (particularly S. aureus)
- Absence of an identified infective focus
- Inadequate antimicrobial therapy 1
Bacteremia Complications and Outcomes
- Mortality rates: 22% at 30 days, 41.4% at 1 year, and 75.8% at 10 years 5
- Metastatic infections: Endocarditis (25-32% risk with S. aureus bacteremia), osteomyelitis, septic arthritis 1, 6
- Long-term consequences: Even 5-year survivors of bacteremia have a 2-fold increased risk of death compared to population controls 5
Clinical Prediction of Bacteremia
For S. aureus pneumonia, a clinical prediction rule for concurrent bacteremia includes:
- Prior antibiotic therapy (2 points)
- Acute lung injury (1 point)
- Need for vasopressors (1 point)
- Higher scores correlate with increased bacteremia prevalence 3
Common Pitfalls in Management
Failure to identify the source: The absence of an identified infective focus is a strong predictor of mortality 1
Inadequate duration of therapy: S. aureus bacteremia requires minimum 14 days of treatment, extending to 4-6 weeks with complications 1
Missing endocarditis: Due to the high risk of endocarditis (25-32%) with S. aureus bacteremia, transesophageal echocardiogram is indicated unless cultures and clinical assessment are negative 72 hours after catheter removal 1
Overlooking catheter removal: In cases of S. aureus infection, the catheter should be removed and systemic antibiotic therapy implemented 1
Ignoring occult bacteremia in children: While the prevalence has declined to 0.17-2% in the post-pneumococcal and Haemophilus influenza type b vaccine era, it remains a concern, particularly in children aged 3-36 months with fever without source 1
The epidemiology of bacteremia has evolved with vaccination and changing resistance patterns, but S. aureus, pneumococcal, and enterococcal infections remain the highest risk for developing bacteremia with significant associated morbidity and mortality.